Elzbieta Obielecka

Head of Strategy at Advanced Accelerator Applications SA

Elzbieta Obielecka

Elzbieta Obielecka

Head of Strategy at Advanced Accelerator Applications SA

Biography

Elzbieta Obielecka is Head of Strategy Executive Leadership Team. Elzbieta Obielecka was appointed Head of Strategy for Advanced Accelerator Applications (AAA), a Novartis company in November 2019. Elzbieta has over 15 years of cross-functional, international experience in the pharmaceutical sector. Prior to joining AAA, Elzbieta was Director, Finance and Business Planning, Worldwide Markets at Celgene since 2017. In this position, she provided strategic and financial guidance, as well as risk and opportunity assessment to leadership of Hematology-Oncology and Immune-Inflammatory franchises, representing a portfolio of more than $5 billion. Elzbieta first joined Celgene in 2014, as Associate Director, Europe, Middle East and Africa Finance & Business Planning. From 2012 to 2014, Elzbieta worked at Alcon Management SA in Geneva. She started as Commercial Manager, Distributor Markets, where she led strategy implementation and the integration process across Ciba Vision distributors after the Novartis/Alcon acquisition, and then became Brand Manager, Daily Contact Lenses for Europe, Middle East and Africa within the Vision Care Franchise. Before this, Elzbieta worked at Ciba Vision Poland, where she was Commercial and Marketing Manager, International Distributor Markets from 2008 to 2012. Elbieta first started her career in the pharmaceutical industry in 2003, as a Sales Force Representative at Berlin Chemie-Menarini and then later at Novartis Consumer Health. Elzbieta holds a Master of Science in Nuclear Physics from the University of Lodz and additional qualifications in Business and Management from the Warsaw School of Economics (SGH), both in Poland.

Overview
RelSci Relationships

738

Contact Data
Trying to get in touch with Elzbieta Obielecka? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Elzbieta Obielecka likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Financial Officer at Advanced Accelerator Applications SA

Relationship likelihood: Strong

Chief Operations Officer at Advanced Accelerator Applications SA

Relationship likelihood: Strong

Chief Commercial Officer at Advanced Accelerator Applications SA

Relationship likelihood: Strong

General Manager, AAA Italy at Advanced Accelerator Applications SA

Relationship likelihood: Strong

General Manager, Gipharma at Advanced Accelerator Applications SA

Relationship likelihood: Strong

Head of Research & Business Development at Advanced Accelerator Applications SA

Relationship likelihood: Strong

Head-Technical Operations at Advanced Accelerator Applications SA

Relationship likelihood: Strong

Head of Quality Assurance at Advanced Accelerator Applications SA

Relationship likelihood: Strong

Global Head of Medical Affairs at Advanced Accelerator Applications SA

Relationship likelihood: Strong

Head of Research & Development at Advanced Accelerator Applications SA

Relationship likelihood: Strong

Paths to Elzbieta Obielecka
Potential Connections via
Relationship Science
You
Elzbieta Obielecka
Head of Strategy at Advanced Accelerator Applications SA
Career History
Head of Strategy
Current

Advanced Accelerator Applications SA is a radiopharmaceutical company, which develops, produces and commercializes molecular nuclear medicine products. It offers research and development in medicinal and pharmaceutical therapeutic products mainly focusing in cardiology and neurology. The company manufactures both diagnostic and therapeutic MNM products for commercialization. Advanced Accelerator Applications was founded in 2002 by Stefano Buono and is headquartered in Saint Genis Pouilly, France.

Senior Manager
Tenure Unconfirmed

Celgene is a global biopharmaceutical company committed to improving the lives of patients worldwide. At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our mission as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions. There are more than 300 clinical trials at major medical centers using compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndromes, chronic lymphocyte leukemia (CLL), non-Hodgkin's lymphoma (NHL), myelofibrosis, small cell lung cancer and prostate cancer. As committed as we are to clinical accomplishment, we are equally committed to patient support, which is a guiding principle at Celgene. We believe all who can benefit from our discoveries should have the opportunity to do so. Celgene puts patients first with industry-leading programs that provide information, support and access to our innovative therapies

Other Affiliations

Elzbieta Obielecka is affiliated with Advanced Accelerator Applications SA, Celgene Corp.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Elzbieta Obielecka. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Elzbieta Obielecka's profile does not indicate a business or promotional relationship of any kind between RelSci and Elzbieta Obielecka.